Mitomycin C augmented glaucoma surgery: Evolution of filtering bleb avascularity, transconjunctival oozing, and leaks

British Journal of Ophthalmology

Volumn 90, Issue 2, 2006, Pages 175-180

  Anand, Nitin ^a   Arora, S ^a   Clowes, M ^a  

^a HUDDERSFIELD ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; AQUEOUS SOLUTION; ARTICLE; FEMALE; FILTERING OPERATION; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; SCLERECTOMY; TRABECULECTOMY; VASCULARIZATION;

AGED; BLISTER; CONJUNCTIVA; CONJUNCTIVAL DISEASES; FEMALE; FLUOROURACIL; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MITOMYCIN; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SCLERA; SURVIVAL ANALYSIS; TIME FACTORS; TRABECULECTOMY; TREATMENT OUTCOME; WOUND HEALING;

EID: 31544450713     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.077800     Document Type: Article

References (42)

1. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1996;121:349-66.
2. Beckers HJ, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol 2003;241:106-10.
3. WuDunn D, Cantor LB, Palanca-Capistrano AM, et al. A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy. Am J Ophthalmol 2002;134:521-8.
4. Hagiwara Y, Yamamoto T, Kitazawa Y. The effect of mitomycin C trabeculectomy on the progression of visual field defect in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 2000;238:232-6.
5. Kim YY, Sexton RM, Shin DH, et al. Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomycin C. Am J Ophthalmol 1998;126:755-62.
6. Mietz H, Krieglstein GK. Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C. Ophthalmic Surg Lasers 1998;29:628-34.
7. Costa VP, Comegno PE, Vasconcelos JP, et al. Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. J Glaucoma 1996;5:193-9.
8. Chen CW, Huang HT, Bair JS, et al. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol 1990;6:175-82.
9. Fluorouracil Filtering Surgery Study. Three-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1993;115:82-92.
10. Akova YA, Bulut S, Dabil H, et al. Late bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmic Surg Lasers 1999;30:146-51.
11. Belyea DA, Dan JA, Stamper RL, et al. Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C. Am J Ophthalmol 1997;124:40-5.
12. Bindlish R, Condon GP, Schlosser JD, et al. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology 2002;109:1336-41.
13. Costa VP, Wilson RP, Moster MR, et al. Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery. Ophthalmic Surg 1993;24:389-94.
14. Dreyer EB, Chaturvedi N, Zurakowski D. Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment. Arch Ophthalmol 1995;113:578-80.
15. Greenfield DS, Liebmann JM, Jee J, et al. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol 1998;116:443-7.
16. Hu CY, Matsuo H, Tomita G, et al. Clinical characteristics and leakage of functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients. Ophthalmology 2003;110:345-52.
17. Membrey WL, Poinoosawmy DP, Bunce C, et al. Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 1 intraocular pressure control and complications. Br J Ophthalmol 2000;84:586-90.
18. Mochizuki K, Jikihara S, Ando Y, et al. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol 1997;81:877-83.
19. Muckley ED, Lehrer RA. Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. Optom Vis Sci 2004;81:499-504.
20. Susanna R Jr, Takahashi W, Nicolela M. Late bleb leakage after trabeculectomy with 5-fluorouracil or mitomycin C. Can J Ophthalmol 1996;31:296-300.
21. Ticho U, Ophir A. Late complications after glaucoma filtering surgery with adjunctive 5-fluorouracil. Am J Ophthalmol 1993;115:506-10.
22. Mandal AK, Vemuganti GK, Ladda N, et al. Partial excision with a conjunctival advancement flap after a relaxing incision for a dissecting glaucoma filtering bleb. Ophthalmic Surg Lasers 2002;33:497-500.
23. Nuyts RM, Felten PC, Pels E, et al. Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony. Am J Ophthalmol 1994;118:225-37.
24. Shields MB, Scroggs MW, Sloop CM, et al. Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C. Am J Ophthalmol 1993;116:673-83.
25. Mietz H, Arnold G, Kirchhof B, et al. Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch Clin Exp Ophthalmol 1996;234:364-8.
26. Matsuo H, Tomidokoro A, Suzuki Y, et al. Late-onset transconjunctival oozing and point leak of aqueous humor from filtering bleb after trabeculectomy. Am J Ophthalmol 2002;133:456-62.
27. Anand N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye 2005;19:442-50.
28. Funnell CL, Clowes M, Anand N. Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy. Br J Ophthalmol 2005;89:694-8.
29. Lamping KA, Bellows AR, Hutchinson BT, et al. Long-term evaluation of initial filtration surgery. Ophthalmology 1986;93:91-101.
30. Poulsen EJ, Allingham RR. Characteristics and risk factors of infections after glaucoma filtering surgery. J Glaucoma 2000;9:438-43.
31. Mochizuki K, Jikihara S, Ando Y, et al. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol 1997;81:877-83.
32. DeBry PW, Perkins TW, Heatley G, et al. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002;120:297-300.
33. Bindlish R, Condon GP, Schlosser JD, et al. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology 2002;109:1336-41.
34. Soltau JB, Rothman RF, Budenz DL, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol 2000;118:338-42.
35. Mietz H. The toxicology of mitomycin C on the ciliary body. Curr Opin Ophthalmol 1996;7:72-9.
36. Schraermeyer U, Diestelhorst M, Bieker A, et al. Morphologic proof of the toxicity of mitomycin C on the ciliary body in relation to different application methods. Graefes Arch Clin Exp Ophthalmol 1999;237:593-600.
37. Anand N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye 2005;19:442-50.
38. Marchini G, Marraffa M, Brunelli C, et al. Ultrasound biomicroscopy and intraocular-pressure-lowering mechanisms of deep sclerectomy with reticulated hyaluronic acid implant. J Cataract Refract Surg 2001;27:507-17.
39. Roters S, Luke C, Jonescu-Cuypers CP, et al. Ultrasound biomicroscopy and its value in predicting the long term outcome of viscocanalostomy. Br J Ophthalmol 2002;86:997-1001.
40. Matsuo H, Tomidokoro A, Tomita G, et al. Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb. Eye 2005;19:23-8.
41. Wells AP, Cordeiro MF, Bunce C, et al. Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology 2003;110:2192-7.
42. Cordeiro MF, Constable PH, Alexander RA, et al. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 1997;38:1639-46.